financetom
Business
financetom
/
Business
/
Edge networking solutions firm Lantronix slightly beats Q1 revenue expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Edge networking solutions firm Lantronix slightly beats Q1 revenue expectations
Nov 5, 2025 2:26 PM

Overview

* Lantronix fiscal Q1 2026 revenue slightly beats analysts' expectations

* Non-GAAP EPS for fiscal Q1 2026 aligns with co's guidance

* Company grew drone OEM engagements to 17, highlighting UAS market demand

Outlook

* Lantronix ( LTRX ) forecasts Q2 FY2026 revenue between $28 mln and $32 mln

* Company expects Q2 FY2026 non-GAAP EPS between $0.02 and $0.04

* Lantronix ( LTRX ) sees long-term opportunities in UAS market supported by defense funding

Result Drivers

* DRONE OEM ENGAGEMENTS - Lantronix ( LTRX ) increased OEM engagements from 10 to 17, reflecting demand in the UAS market

* TECHNOLOGY INTEGRATION - Integrated Gremsy and Teledyne FLIR technologies into Edge AI drone solutions, enhancing performance

* NEW PLATFORM LAUNCHES - Launched Kompress.ai and EdgeFabric.ai to advance asset monitoring and edge AI deployment

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Slight $29.79 $29.55

Revenue Beat* mln mln (4

Analysts

)

Q1 Net -$1.40

Income mln

Q1 Basic -$0.04

EPS

Q1 Gross $13.35

Profit mln

Q1 -$1.53

Income mln

From

Operatio

ns

Q1 -$1.36

Pretax mln

Profit

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the communications & networking peer group is "buy"

* Wall Street's median 12-month price target for Lantronix Inc ( LTRX ) is $5.25, about 11.2% above its November 4 closing price of $4.66

* The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lantronix Says CFO Jeremy Whitaker Resigned
Lantronix Says CFO Jeremy Whitaker Resigned
Sep 16, 2024
09:48 AM EDT, 09/16/2024 (MT Newswires) -- Lantronix ( LTRX ) said Monday that Chief Financial Officer Jeremy Whitaker resigned and left the company on Sept. 13. Whitaker accepted the CFO role at a private company, Lantronix ( LTRX ) said. Brent Stringham, who is Lantronix's ( LTRX ) controller, has been named interim CFO as the company searches for...
Citi taps tech chief Ryan to fix data management issues alongside Selva, memo shows
Citi taps tech chief Ryan to fix data management issues alongside Selva, memo shows
Sep 16, 2024
(Reuters) - Citigroup ( C/PN ) has tasked technology head Tim Ryan to work alongside Chief Operating Officer Anand Selva in fixing the bank's longstanding data management issues, according to a memo seen by Reuters on Monday. Ryan, who joined Citi in June from PwC's U.S. franchise, will jointly lead the data program along with Selva, who will continue to...
Lakeland Financial Insider Bought Shares Worth $292,680, According to a Recent SEC Filing
Lakeland Financial Insider Bought Shares Worth $292,680, According to a Recent SEC Filing
Sep 16, 2024
10:10 AM EDT, 09/16/2024 (MT Newswires) -- Stephanie R Leniski, Senior Vice President, on September 13, 2024, executed a purchase for 4,500 shares in Lakeland Financial ( LKFN ) for $292,680. Following the Form 4 filing with the SEC, Leniski has control over a total of 7,974 shares of the company, with 7,974 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/721994/000072199424000127/xslF345X05/wk-form4_1726495291.xml Price: 65.57,...
Ascendis Pharma Says Trial of Potential Dwarfism Drug Achieved Primary Endpoint
Ascendis Pharma Says Trial of Potential Dwarfism Drug Achieved Primary Endpoint
Sep 16, 2024
10:06 AM EDT, 09/16/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday a trial of TransCon CNP, navepegritide, in children with achondroplasia achieved its primary endpoint of improving annualized growth velocity, or AGV, compared to a placebo. The company said the trial included 84 children with achondroplasia, a type of 'dwarfism,' aged between 2 years and 11 years....
Copyright 2023-2026 - www.financetom.com All Rights Reserved